Patents by Inventor John P. Mullally

John P. Mullally has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8099459
    Abstract: Transmit user feedback from a user to a web syndication author. A first communication link is opened. Content data from the web syndication author is received. The received content data is stored on a first client device. The opened first communication link is terminated after receiving the content data. User behavior data is collected as a function of user interactions with the received content data on the first client device after terminating the first communication link. User feedback including the collected user behavior data is transmitted to the web syndication author by opening a second communication link.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: January 17, 2012
    Assignee: Microsoft Corporation
    Inventors: Daniel Plastina, Andrew J. Jaffray, Andrew L. Silverman, John P. Mullally, IV, Joshuah Vincent
  • Patent number: 7890513
    Abstract: Methods, computer-readable media, and systems for providing a user with media item ratings based upon media item ratings of a community of related users. The user sends information about herself to the system. The system places the user in a community of users based upon the user information and provides media item ratings to members of the community based upon media item ratings by other community members.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: February 15, 2011
    Assignee: Microsoft Corporation
    Inventors: Daniel Plastina, Edward T. Gausman, John P. Mullally, IV, Michael Novak, Pradeep Jha
  • Publication number: 20080254053
    Abstract: A method and composition for reducing highly sensitive C-reactive protein is provided for the treatment of Type I and Type II diabetes which is achieved through the daily administration of a leukotriene inhibitor, an antihistamine and a corticosteroid. The composition may be administered singly or as a single medicament. Typically, the leukotriene inhibitor and antihistamine are administered orally and the steroid nasally infused.
    Type: Application
    Filed: June 13, 2008
    Publication date: October 16, 2008
    Inventor: John P. Mullally
  • Publication number: 20070299935
    Abstract: Transmit user feedback from a user to a web syndication author. A first communication link is opened. Content data from the web syndication author is received. The received content data is stored on a first client device. The opened first communication link is terminated after receiving the content data. User behavior data is collected as a function of user interactions with the received content data on the first client device after terminating the first communication link. User feedback including the collected user behavior data is transmitted to the web syndication author by opening a second communication link.
    Type: Application
    Filed: June 23, 2006
    Publication date: December 27, 2007
    Applicant: MICROSOFT CORPORATION
    Inventors: Daniel Plastina, Andrew J. Jaffray, Andrew L. Silverman, John P. Mullally, Joshuah Vincent
  • Publication number: 20040192660
    Abstract: A method and composition for reducing highly sensitive C-reactive protein to improve the vision of a user is achieved through the daily administration of a leukotriene inhibitor, and antihistamine and a corticosteroid. The composition may be administered singly or as a single medicament. Typically, the leukotriene inhibitor and antihistamine are administered orally and the steroid nasally infused.
    Type: Application
    Filed: April 8, 2004
    Publication date: September 30, 2004
    Inventor: John P. Mullally
  • Publication number: 20040180868
    Abstract: A method and composition for reducing C-reactive protein for reducing systemic inflammations in the body of a user is achieved through the daily administration of a leukotriene inhibitor, and antihistamine and a corticosteroid. The composition may be administered singly or as a single medicament. Typically, the leukotriene inhibitor and antihistamine are administered orally.
    Type: Application
    Filed: March 11, 2004
    Publication date: September 16, 2004
    Inventor: John P. Mullally